Status:
COMPLETED
Effect of Genetic Polymorphism on the Occurrence of Post-Operative Atrial Fibrillation After CABG
Lead Sponsor:
Ain Shams University
Collaborating Sponsors:
Misr International University
Conditions:
Coronary Bypass Graft Surgery
Atrial Fibrillation
Eligibility:
All Genders
18-100 years
Brief Summary
Postoperative Atrial Fibrillation (POAF) is one of the most common complications following coronary artery bypass grafting (CABG) occurring to 20% - 40% of patients. It is associated with prolonged ho...
Eligibility Criteria
Inclusion
- Age above 18 years.
- Candidates for CABG surgery without a concurrent valve surgery.
- Patients receiving perioperative beta blockers before new onset of postoperative AF.
Exclusion
- Patients who have either persistent or permanent AF, atrial flutter or atrial tachycardia on ECG obtained on the day of the operation.
- Serum creatinine \>2 mg/dL before the surgery.
- Uncontrolled thyroid disease.
- Recent treatment with amiodarone before the occurrence of POAF
Key Trial Info
Start Date :
March 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 7 2021
Estimated Enrollment :
256 Patients enrolled
Trial Details
Trial ID
NCT03871647
Start Date
March 11 2019
End Date
March 7 2021
Last Update
November 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Cardiovascular & Thoracic Academy - Ain Shams University.
Cairo, Egypt